Takeshi Arashiro

Chiba University — Japan

Medicine · Health Sciences

15h-index892citations59works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(24), COVID-19 Clinical Research Studies(19), COVID-19 epidemiological studies(15), SARS-CoV-2 detection and testing(12), Respiratory viral infections research(10)

Publications59 total

EE57 Assessing Public Health and Economic Benefits of Nirsevimab or RSVpreF for Preventing RSV-Related Outcomes in Japanese Infants
Value in Health·2025
What Drives Respondents to Seroepidemiological Surveys? Insights From COVID-19 and Implications for Future Pandemics
Journal of Epidemiology·2025Open Access
A pluralistic approach to interpreting surveillance data: The likely decline in the occurrence of invasive pneumococcal disease in Japan during the COVID-19 pandemic
Annals of Epidemiology·2025
Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history
Communications Medicine·2025· 1 citedOpen Access
Cost-effectiveness and public health impact of using high dose influenza vaccine in the Japanese older adults
Journal of Medical Economics·2025· 3 citedOpen Access
Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan
Infectious Diseases and Therapy·2025· 7 citedOpen Access
Factors associated with COVID-19 in-hospital death and COVID-19 vaccine effectiveness against COVID-19 hospitalization in the Philippines during pre-omicron and omicron period: A case-control study (MOTIVATE-P study)
Epidemiology and Infection·2024· 2 citedOpen Access
The Burden of Seasonal Influenza and Its Potential Complications Among Older Japanese Adults: A Real‐World Database Study
Influenza and Other Respiratory Viruses·2024· 4 citedOpen Access
Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011–2022: A Database Study
Influenza and Other Respiratory Viruses·2024· 4 citedOpen Access
Respiratory Syncytial Virus Infection Notification Trends and Interpretation of the Reported Case Data, 2018–2021, Japan
Japanese Journal of Infectious Diseases·2024· 3 citedOpen Access
Prospective hospital-based cohort studies of Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan
International Journal of Infectious Diseases·2024· 4 citedOpen Access
Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger than 5 years in Japan, 2011-2022: A database study
2024Open Access
Sentinel Surveillance of COVID-19: The Importance of Epidemiologic Concepts and Reasoning
Journal of Epidemiology·2024· 1 citedOpen Access
Serum anti-nucleocapsid antibody level induced after primary infection is an immunological surrogate of protection against SARS-CoV-2 re-infection in hybrid immunity holders
2024Open Access
Letter to the Editor: Pathogens detected from patients with acute respiratory infections negative for SARS-CoV-2, Saitama, Japan, 2020
Western Pacific surveillance response journal·2024· 2 citedOpen Access
Usefulness of a Pluralistic Approach in Sentinel Surveillance: Seasonal Influenza Activity Based on Case Counts per Sentinel Site in the National Epidemiological Surveillance of Infectious Diseases Program and Test Counts, Case Counts, and Test Positivity from the National Hospital Organization
Japanese Journal of Infectious Diseases·2024· 4 citedOpen Access
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection
Proceedings of the National Academy of Sciences·2023· 44 citedOpen Access
COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)
Vaccine·2023· 11 citedOpen Access
Epidemiology of syphilis among female sex workers and pregnant women during a period of increasing syphilis among women in Japan, 2019–2021
Sexually Transmitted Infections·2023· 3 cited
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan
Vaccine·2023· 12 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Motoi Suzuki(21), Tadaki Suzuki(17), Yuzo Arima(16), Takayuki Kanno(10), Shô Miyamoto(10), Takuri Takahashi(9), Akira Ainai(8), Shuetsu Fukushi(7), Hitomi Kinoshita(7), Tsuguto Fujimoto(6), Saya Moriyama(6), Shun Iida(6), Akira Ueno(6), Yoshimasa Takahashi(6), Chris Smith(6), Martin L. Hibberd(6), Koya Ariyoshi(6), Tomoe Shimada(6), Tomimasa Sunagawa(6), Miyako Otsuka(6)